Kahraman, S. Et Al. 2024. Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study. BMC CANCER , no.1 .

Kahraman, S., Hizal, M., Demirel, B. C., GÜVEN, D. C., GÜMÜŞAY, Ö., OYAN ULUÇ, B., ... BAYRAM, E.(2024). Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study. BMC CANCER , no.1.

Kahraman, Seda Et Al. "Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study," BMC CANCER , no.1, 2024

Kahraman, Seda Et Al. "Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study." BMC CANCER , no.1, 2024

Kahraman, S. Et Al. (2024) . "Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study." BMC CANCER , no.1.

@article{article, author={Seda Kahraman Et Al. }, title={Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study}, journal={BMC CANCER}, year=2024}